FDA Import Refusal SCS-1671903-3/11/1 — Novartis Pharmaceuticals Canada Inc.
The FDA refused shipment SCS-1671903-3/11/1 from Novartis Pharmaceuticals Canada Inc. (Canada) on Sep 14, 2020. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,3280 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 14, 2020
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 66VAL99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,3280